UPPTHERA
- Business Model
- B2B
- Website
- uppthera.com
About
Biotech company developing PROTAC-based cancer therapeutics targeting protein degradation.
Summary
UPPTHERA is a Biotech company.
Similar Companies
BeiGeneIPO
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020

AsymchemIPO
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020

Abogen Biosciences
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021

Eikon TherapeuticsIPO
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Hayward, United States201–500Artificial Intelligence, Biotech
Series D·$1.1B·Feb 2025
Avenzo
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
San Diego, United States1–10Biotech, Oncology
Series B·$832.0M·Sep 2025
Treeline Biosciences
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$821.8M·Sep 2025